Learning Objectives:

1. Discuss current management of HF

2. Role of cardiac myosin activator Omecamtiv Mecarbil in HF treatment

 

Session date: 
Friday, July 30, 2021 - 7:30am to 8:30am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Iva Minga, MD